[1] Lavarone M, Alimenti E, Tada T, et al. Incidence and predictors of esophagogastric varices bleeding in patients with hepatocellular carcinoma in lenvatinib[J]. Liver Cancer,2024,13(2):215-226. [2] Gralnek I M, Garcia-Pagan J C, Hernandez-Gea V. Challenges in the management of esophagogastric varices and variceal hemorrhage in cirrhosis - a narrative review[J]. Am J Med,2024,137(3):210-217. [3] Chikamori F, Mizobuchi K, Hamada R, et al. Emergency transileocolic vein obliteration for life-threatening bleeding from gastric varices[J]. Radiol Case Rep,2023,18(4):1570-1575. [4] Wu R, Liu K, Shi C, et al. Risk factors for portal hypertensive gastropathy[J]. BMC Gastroenterol,2022,22(1):436. [5] 陈世耀,蒋颖溢,黄晓铨. 食管胃静脉曲张出血合并门静脉血栓的临床监测与处理[J]. 中华消化内镜杂志,2022,39(5):343-346. [6] 俞斌,屠军,沈玉玲. AIMS65评分预测肝硬化食管胃底静脉曲张破裂出血患者死亡的价值[J]. 胃肠病学和肝病学杂志,2022,31(7):737-742. [7] de Franchis R. Expanding consensus in portal hypertension: report of the baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension[J]. J Hepatol,2015,63(3):743-752. [8] de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension[J]. J Hepatol,2022,76(4):959-974. [9] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志,2019,27(11):846-865. [10] Luo R, Gao J, Gan W, et al. Clinical-radiomics nomogram for predicting esophagogastric variceal bleeding risk noninvasively in patients with cirrhosis[J]. World J Gastroenterol,2023,29(6):1076-1089. [11] Mei L, Ma Y, Zhao L, et al. Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis[J]. BMC Gastroenterol,2022,22(1):515. [12] Colombo C, Lanfranchi C, Tosetti G, et al. Management of liver disease and portal hypertension in cystic fibrosis: a review[J]. Expert Rev Respir Med,2024,18(5):269-281. [13] Ma A S, Thuluvath P J. The role of endoscopy for primary and secondary prophylaxis of variceal bleeding[J]. Gastrointest Endosc Clin N Am,2024,34(2):231-248. [14] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 中华肝脏病杂志,2022,30(10):1029-1043. [15] 喻雪珂,黎孟玲,彭思远,等. 食管胃底静脉曲张破裂出血对肝硬化患者1年死亡结局的影响及相关因素研究[J]. 中国全科医学,2023,26(14):1745-1752. [16] 伍婷,唐奇远,廖雪姣,等. 肝硬化患者并发食管胃底静脉曲张破裂出血的危险因素及再出血防治[J]. 肝脏,2023,28(8):903-906,911. [17] 涂建军,方翔,蒋琪,等. 乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者再出血影响因素及预测模型的建立[J]. 实用肝脏病杂志,2023,26(5):686-689. [18] 陈方璐,雎瑶,王玲玲,等. 乙肝肝硬化并发食管胃底静脉曲张破裂出血的危险因素分析[J]. 血管与腔内血管外科杂志,2023,9(9):1128-1132. [19] 张志远,邓卉. 基于超声及实验室参数的Logistic回归模型预测肝硬化食管胃底静脉曲张破裂出血的临床价值[J]. 临床超声医学杂志,2024,26(6):491-495. [20] 申艳,赵正斌,李潇,等. 肝硬化门静脉血栓合并食管胃底静脉曲张破裂出血的危险因素及列线图模型构建[J]. 中华肝脏病杂志,2023,31(10):1035-1042. [21] 曾阿娟,郑俊福,张世斌,等. 肝硬化食管胃底静脉曲张破裂出血床旁急诊内镜治疗的效果及危险因素[J]. 胃肠病学和肝病学杂志,2023,32(9):982-991,996. [22] 张雯,宋牡丹,邓雪婷,等. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版),2023,13(6):456-460. [23] 逯世林,张娜,王琳,等. 抗凝血酶Ⅲ在乙型肝炎肝硬化失代偿期和并发食管胃底静脉曲张破裂出血中的评估价值[J]. 中华消化杂志,2022,42(11):770-776. [24] 李红,胡林莉,黄树丽. 超声内镜联合风险评估系统评分对肝硬化患者合并食管胃底静脉曲张破裂出血的诊断价值[J]. 广东医学,2022,43(8):994-1000. [25] 宋亚华,薛琼,秦赟,等. 不同内镜检查时间对肝硬化食管胃底静脉曲张破裂出血患者再出血及预后的影响[J]. 现代消化及介入诊疗,2023,28(3):339-342. [26] Kalista K F, Hanif S A, Nababan S H, et al. The clinical role of endoscopic ultrasound for management of bleeding esophageal varices in liver cirrhosis[J]. Case Rep Gastroenterol,2022,16(2):295-300. [27] Wang Z, Zeng Z, Chen L, et al. Endoscopic ultrasonography-guided injection of cyanoacrylate in the treatment of gastroesophageal varices type 1: a single-center randomized study[J]. Surg Endosc,2023,37(11):8277-8284. [28] Chikamori F, Maeda A, Sharma N. An emergency hybrid procedure that combines endoscopic treatment with partial splenic embolization for bleeding esophagogastric varices[J]. Radiol Case Rep,2022,17(5):1640-1645. [29] Tan B G, Yang L Q, Wu Y P, et al. Combinations of liver lobe and spleen volumes obtained on magnetic resonance imaging to predict esophagogastric variceal bleeding in hepatitis B-related cirrhotic patients: a prospective cohort study[J]. Medicine (Baltimore),2022,101(38):e30616. |